5 Key Takeaways

• 1

  Hybrid closed-loop insulin therapy reduces the risk of severe hypoglycemic coma by 38% in pediatric and adolescent patients with type 1 diabetes.

• 2

  The incidence of diabetic ketoacidosis was 1.4 times higher in patients using hybrid closed-loop therapy compared to those on standard insulin pump therapy.

• 3

  Patients using hybrid closed-loop therapy achieved a mean reduction of 0.5% in HbA1c levels and a 12% improvement in time-in-range glucose levels.

• 4

  Technical issues leading to interruptions in insulin delivery significantly contributed to diabetic ketoacidosis episodes among hybrid closed-loop therapy users.

• 5

  The study emphasized the need for proper device management, user training, and emergency protocols to mitigate risks associated with hybrid closed-loop therapy.